Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

Ossenkoppele, G; Graveland, W; Sonneveld, P; Daenen, S; Biesma, D; Verdonck, L; Schaafsma, M; Westveer, P; Peters, G; Noordhuis, P; Muus, P; Selleslag, D; van der Holt, B; Delforge, Michel; Lowenberg, B; Verhoef, Gregor

Blood

Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

Author:

Ossenkoppele, G

Graveland, W ; Sonneveld, P ; Daenen, S ; Biesma, D ; Verdonck, L ; Schaafsma, M ; Westveer, P ; Peters, G ; Noordhuis, P ; Muus, P ; Selleslag, D ; van der Holt, B ; Delforge, Michel ; Lowenberg, B ; Verhoef, Gregor

Keywords:

Science & Technology, Life Sciences & Biomedicine, Hematology, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, Immunology, 3101 Biochemistry and cell biology, 3201 Cardiovascular medicine and haematology, 3213 Paediatrics

Blood Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

Author:

Keywords:

Blood

Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML